RSCI (Redwood Scientific Technologies) ROE % Adjusted to Book Value: 0.00% (As of Dec. 2023)


What is Redwood Scientific Technologies ROE % Adjusted to Book Value?

Redwood Scientific Technologies RSCI ROE % Adjusted to Book Value is 0.00% as of Dec. 2023.

Redwood Scientific Technologies's ROE % for the quarter that ended in Dec. 2023 was 0.00%. Redwood Scientific Technologies's PB Ratio for the quarter that ended in Dec. 2023 was N/A. Redwood Scientific Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was N/A.

Redwood Scientific Technologies ROE % Adjusted to Book Value Related Terms

Redwood Scientific Technologies ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Redwood Scientific Technologies's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies ROE % Adjusted to Book Value Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
0.00 0.00 0.00 0.00

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value 0.00 0.00 0.00 0.00

RSCI vs RAPH, FLGC, TXMD: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Redwood Scientific Technologies's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redwood Scientific Technologies ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redwood Scientific Technologies's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Redwood Scientific Technologies's ROE % Adjusted to Book Value falls into.


Redwood Scientific Technologies ROE % Adjusted to Book Value Calculation

Redwood Scientific Technologies's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Redwood Scientific Technologies's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Redwood Scientific Technologies (RSCI) has a ROE % Adjusted to Book Value of 0.00% as of Dec. 2023. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Redwood Scientific Technologies and its competitors.
Is Redwood Scientific Technologies' ROE % Adjusted to Book Value too high?
Redwood Scientific Technologies' current ROE % Adjusted to Book Value is 0.00%.
How does Redwood Scientific Technologies' ROE % Adjusted to Book Value compare to RAPH and FLGC?
Redwood Scientific Technologies' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Redwood Scientific Technologies and its competitors. Redwood Scientific Technologies's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redwood Scientific Technologies stock overvalued right now?
Redwood Scientific Technologies (RSCI) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Redwood Scientific Technologies (RSCI), the current ROE % Adjusted to Book Value is 0.00% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.